Clinical and radiological characteristics of tumefactive demyelinating lesions: Follow-up study

Multiple Sclerosis Journal

Volumn 18, Issue 10, 2012, Pages 1448-1453

  Altintas, A ^a   Petek, B ^b   Isik, N ^c   Terzi, M ^d   Bolukbasi, F ^a   Tavsanli, M ^a   Saip, S ^a   Boz, C ^e   Aydin, T ^c   Arici Duz, O ^c   Ozer, F ^b   Siva, A ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^e KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

demyelinating disease; magnetic resonance imaging; multiple sclerosis; oligoclonal banding; relapsing remitting multiple sclerosis; tumefactive demyelinating lesion

Indexed keywords

OLIGOCLONAL BAND; STEROID;

ADULT; ARTICLE; BRAIN BIOPSY; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT RESPONSE; TUMEFACTIVE DEMYELINATING LESION;

EID: 84867030759     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512438237     Document Type: Article

References (24)

1. Dastgir J, DiMario FJ. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: Review of the literature and treatment proposal. J Child Neurol. 2009 ; 24: 431-437
2. Cucurella MG, Rovira A, Grive E, et al. Serial proton spectroscopy, magnetization transfer ratio and T2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed. 2002 ; 15: 284-292
3. Ernst T, Chang L, Walot I, et al. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurol. 1998 ; 51: 1486-1488
4. Saindane AM, Cha S, Law M, et al. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR. 2002 ; 23: 1378-1386
5. Masdeu JC, Quinto C, Olivera C, et al. Open ring imaging sign: Highly specific for atypical brain demyelination. Neurol. 2000 ; 11: 1427-1433
6. Given CA, Stevens BS, Lee C. The MRI appearance of tumefactive demyelinating lesions. AJR. 2004 ; 182: 195-199
7. Dagher AP, Smirniotopoulos J. Tumefactive demyelinating lesions. Neuroradiol J. 1996 ; 38: 560-565
8. Sinha MK, Garg RK, Bhatt MLB, et al. Tumefactive demyelinating lesion: Experience with two unusual patients. J Postgrad Med. 2010 ; 56: 146-149
9. Kiriyama T, Kataoka H, Taoka T, et al. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30mm. J Neuroimaging. 2011 ; 21: 69-77
10. Cianfoni A, Niku S, Imbesi SG. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR. 2007 ; 28: 272-277
11. Xia L, Lin S, Wang Z, et al. Tumefactive demyelinating lesions: Nine cases and a review of the literature. Neurosurg Rev. 2009 ; 32: 171-179
12. Malhotra HS, Jain KK, Agarwal A, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in vivo proton MR spectroscopy. Mult Scler. 2009 ; 15: 193-203
13. Poser S, Luer W, Bruhn H, et al. Acute demyelinating disease: Classification and noninvasive diagnosis. Acta Neurol Scand. 1992 ; 86: 579-585
14. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol. 1993 ; 33: 18-27
15. Wood DD, Bilbao JM, O'Connors P, et al. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol. 1996 ; 40: 18-24
16. Lucchinetti CF, Gavrilova RH, Metz I, et al. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis. Brain. 2008 ; 131: 1759-1775
17. Selkirk SM, Shi J. Relapsing remitting tumefactive multiple sclerosis. Mult Scler. 2005 ; 11: 731-734
18. Kantarci O, Siva A, Eraksoy M, et al. Survival and predictors of disability in Turkish MS patients. Neurol. 1998 ; 51: 765-772
19. Comi G. Multiple sclerosis: Pseudotumoral forms. Neurol Sci. 2004 ; 25: 374-379
20. Giang DW, Poduri KR, Eskin TA, et al. Multiple sclerosis masquerading as a mass lesion. Neuroradiol J. 1992 ; 34: 150-154
21. Martinelli V, Comi G, Filippi M, et al. Paraclinical tests in acute optic neuritis: Basal data and results of short term follow-up. Acta Neurol Scand. 1991 ; 84: 231-236
22. Frederiksen JL, Larsson HB, Olesen J. Correlation of magnetic resonance imaging and CSF findings in patients with acute monosymptomatic optic neuritis. Acta Neurol Scand. 1992 ; 86: 317-322
23. Rolack LA, Beck RW, Paty DW, et al. Cerebrospinal fluid in acute optic neuritis: Experience of the optic neuritis treatment trial. Neurol. 1996 ; 46: 368-372
24. Tumani H, Tourtellotte WW, Peter JB, et al. Acute optic neuritis: Combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. J Neurol Sci. 1998 ; 155: 44-49